2025年急性髓性白血病的管理和研究
Hagop M Kantarjian1, Courtney D DiNardo1, Tapan M Kadia1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
CA: a cancer journal for clinicians
|December 10, 2024
概括
自2017年以来,急性髓性白血病 (AML) 研究取得了重大进展,有12种新药被批准. 本综述涵盖了前线和后线AML疗法以及未来的研究方向.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在历史上,急性髓性白血病 (AML) 的标准治疗依赖于cytarabine和anthracyclines.
- 血液造血干细胞移植,高剂量细胞氨酸,支持性护理和针对急性前兆细胞白血病的向疗法取得了重大进展.
研究的目的:
- 审查急性髓性白血病 (AML) 的前线和后线治疗方法.
- 讨论AML治疗中的新兴研究方向和新型治疗剂.
主要方法:
- 对AML药物的最新监管批准和临床试验数据的审查.
- 针对性治疗的分析,包括BCL2抑制剂,氨酸激酶抑制剂和抗体-药物合物.
- 讨论新型药物,如脑膜抑制剂和低甲基化剂.
主要成果:
- 自2017年以来,美国已批准12种药物用于AML治疗.
- 已批准的药物包括venetoclax,gemtuzumab,ozogamicin,midostaurin,gilteritinib,quizartinib,ivosidenib,olutasidenib,enasidenib,口服azacitidine,CPX351,glasdegib和revumenib.这些药物被批准使用的药物包括venetoclax,gemtuzumab,ozogamicin,midostaurin,gilteritinib,quizartinib,ivosidenib,olutasidenib,enasidenib,口服azacitidine,CPX351,glasdegib和revumenib.这些药物被批准使用的药物包括venetoclax,gemtuzumab,ozogamicin,midostaurin,glutathione,glutathione,glutathione和glutathione.
- 新兴疗法,如脑膜抑制剂和CD123向剂,显示出有前途的结果.
结论:
- 对AML的治疗格局随着众多新药的批准而大幅发展.
- 未来的研究应该集中在新的向疗法,抗体-药物合物和组合策略上,以改善AML的结果.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.1K
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:22Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284